ORCID: https://orcid.org/0000-0003-1770-8323
(2024):
Protocol for identifying properties of ERBB receptor antagonists using the barcoded ERBBprofiler assay.
In: STAR Protocols, Vol. 5, No. 2, 102987
[PDF, 6MB]
Abstract
The ERBBprofiler assay measures compound effects on ERBB family receptors and key downstream signaling pathways that are implicated in cancer or other complex diseases. Here, we present a protocol for identifying properties of ERBB receptor antagonists using the barcoded ERBBprofiler assay. We describe steps for in-solution transfection, cell treatment, combined processing of samples, amplification and indexing of PCRs, sequencing, and data analysis. This approach allows for the simultaneous assessment of drug effects and cell-type-dependent effects. For complete details on the use and execution of this protocol, please refer to Popović et al.
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine > Medical Center of the University of Munich > Clinic and Polyclinic for Psychiatry and Psychotherapy |
| Subjects: | 600 Technology > 610 Medicine and health |
| URN: | urn:nbn:de:bvb:19-epub-120155-3 |
| ISSN: | 26661667 |
| Language: | English |
| Item ID: | 120155 |
| Date Deposited: | 27. Aug 2024 09:58 |
| Last Modified: | 27. Aug 2024 13:11 |
| DFG: | Gefördert durch die Deutsche Forschungsgemeinschaft (DFG) - 491502892 |
